Strides Pharma Science
STARNSE

Strides Pharma Science

₹977.2039.45 (4.21%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk
Strides Pharma to acquire Sandoz's generic brands in Africa for $12M. Deal finalization expected by Q2 FY27, subject to regulatory approvals.
Livesquawk
Strides Pharma Q3 net profit rises to ₹2B from ₹880M YoY.